Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

1.404 -0.026 (-1.81%)
Streaming Delayed Price Updated: 12:04 PM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4
Intelligent Bio forecasts 16% revenue growth for Q4 2025 and strengthens FDA filing with new data as it expands global reach and system capabilities. 
Via Benzinga
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (NASDAQ: INBS) Wins Major Contract With London Public Transport Operator
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Announces $3.8 Million Warrant Exercise Agreement
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Strengthens FDA 510(k) Submission With New Security and Performance Data
Via Investor Brand Network
Topics Cannabis
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
Intelligent Bio strengthens its FDA 510(k) submission with new data, cybersecurity tests, and advanced fingerprint sweat analysis technology. 
Via Benzinga
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Global Reach with SMARTOX Distribution Deal
Via Investor Brand Network
Topics Cannabis
EXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch
Intelligent Bio expands global reach with SMARTOX deal to distribute its sweat-based drug detection patch across markets outside the U.S. and Canada. 
Via Benzinga
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Non-Invasive Drug Testing Portfolio With SmarTest Patch
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Present Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
Via Investor Brand Network
Topics Cannabis
EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout
Intelligent Bio Solutions expands into environmental services as Managed Waste Service rolls out its drug testing system across New South Wales sites. 
Via Benzinga
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6
Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology. 
Via Stocktwits
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
Via Investor Brand Network
Topics Cannabis
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing
Intelligent Bio grows U.S. forensic market presence via SMARTOX, with 7,000+ tests run and FDA clearance underway for wider market entry. 
Via Benzinga
InvestorNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
Via Investor Brand Network
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (Nasdaq: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout
Via Investor Brand Network
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins
Via Investor Brand Network
Topics Cannabis Intellectual Property
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%
Intelligent Bio Solutions reported a Q3 loss of 44 cents per share with a 20% revenue rise from Q2 and 91% year-over-year gross profit growth. 
Via Benzinga
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Via Investor Brand Network
Topics Cannabis Intellectual Property
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its intellectual property portfolio. 
Via Benzinga
Topics Intellectual Property
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch
Intelligent Bio Solutions awaits FDA clearance for its fingerprint drug test, aiming for a 2025 U.S. launch and expanding its presence in the multi-billion market. 
Via Benzinga
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.